Although serum galectin-3 in the whole studied group of patients with COVID-19 did not differ as compared to healthy subjects (Table 2), a significant difference was observed between the patients with pneumonia and the healthy persons (p = 0.009; Figure 1). This evidence concerns the gene LGALS3 and pneumonia.